Drug Guide
Potassium Chloride
Classification
Therapeutic: Electrolyte, Mineral Supplement
Pharmacological: Potassium ion
FDA Approved Indications
- Hypokalemia (low serum potassium levels)
- Potassium supplementation in cases of potassium deficiency due to diuretics, vomiting, diarrhea, or other causes
Mechanism of Action
Potassium chloride replenishes potassium levels in the body, correcting hypokalemia and maintaining proper cellular, nerve, and muscle function.
Dosage and Administration
Adult: Dose varies based on serum potassium levels; typically 20-80 mEq per day divided into several doses.
Pediatric: Dose based on age and weight, usually 1-2 mEq/kg/day divided into multiple doses.
Geriatric: Adjust dose considering renal function and risk of hyperkalemia.
Renal Impairment: Use with caution; dose adjustments may be necessary to prevent hyperkalemia.
Hepatic Impairment: Use caution; monitor serum potassium levels.
Pharmacokinetics
Absorption: Rapidly absorbed from the gastrointestinal tract.
Distribution: Distributed throughout the total body water.
Metabolism: Not significantly metabolized.
Excretion: Primarily excreted unchanged via the kidneys.
Half Life: Approximately 2-3 hours in individuals with normal renal function.
Contraindications
- Hyperkalemia
- Impaired renal function with risk of potassium retention
- Acidosis
Precautions
- Use with caution in conditions such as Addison's disease, dehydration, or extensive tissue breakdown. Monitor serum potassium regularly. Emergency management of hyperkalemia should be available.
Adverse Reactions - Common
- Gastrointestinal irritation or discomfort (Uncommon)
Adverse Reactions - Serious
- Hyperkalemia (nausea, weakness, arrhythmias) (Rare)
- Cardiac arrest (in severe hyperkalemia) (Rare)
Drug-Drug Interactions
- Potassium-sparing diuretics (e.g., spironolactone)
- ACE inhibitors (e.g., enalapril)
- ARBs (e.g., losartan)
- NSAIDs
Drug-Food Interactions
- Salt substitutes containing potassium
Drug-Herb Interactions
N/ANursing Implications
Assessment: Monitor serum potassium levels, renal function, and ECG in patients on therapy.
Diagnoses:
- Risk for electrolyte imbalance
- Risk for impaired gas exchange due to arrhythmias
Implementation: Administer with meals or as directed, preferably with a full glass of water. Educate patient on signs of hyperkalemia.
Evaluation: Assess serum potassium levels regularly to ensure therapeutic levels and avoid toxicity.
Patient/Family Teaching
- Take medication exactly as prescribed.
- Do not administer if you have hyperkalemia or kidney disease.
- Report symptoms of hyperkalemia: muscle weakness, irregular heartbeat, or numbness.
- Avoid high-potassium foods and salt substitutes containing potassium unless advised.
Special Considerations
Black Box Warnings:
- Potential for hyperkalemia, which can be fatal.
- Use with caution in patients with renal impairment or those taking other potassium-sparing medications.
Genetic Factors: None specific.
Lab Test Interference: May interfere with certain laboratory tests measuring serum potassium.
Overdose Management
Signs/Symptoms: Severe hyperkalemia: muscle weakness, paralysis, cardiac arrhythmias, even cardiac arrest.
Treatment: Immediate discontinuation of potassium intake, administer calcium gluconate intravenously to stabilize cardiac membranes, use agents like sodium bicarbonate or insulin with glucose to shift potassium into cells, and consider dialysis in severe cases.
Storage and Handling
Storage: Store at room temperature away from moisture and heat.
Stability: Stable under normal conditions for the duration of the expiration date.